Haleon plc, a leading global consumer healthcare company, is headquartered in Great Britain and operates extensively across Europe, North America, and Asia. Founded in 2022, Haleon emerged from a spin-off of GlaxoSmithKline's consumer healthcare division, marking a significant milestone in the industry. Specialising in over-the-counter medicines, oral health, and wellness products, Haleon offers a diverse portfolio that includes well-known brands such as Sensodyne, Panadol, and Voltaren. These products are distinguished by their commitment to science-backed efficacy and consumer trust. With a strong market position, Haleon is dedicated to improving everyday health and well-being, making it a notable player in the consumer healthcare sector. The company's focus on innovation and sustainability further enhances its reputation as a forward-thinking leader in the industry.
How does Haleon plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Haleon plc's score of 88 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Haleon plc reported carbon emissions of approximately 2,000,000 kg CO2e for Scope 1 and about 3,000,000 kg CO2e for Scope 2, totalling around 5,000,000 kg CO2e for both scopes combined in Great Britain. Globally, the company’s emissions included approximately 68,000,000 kg CO2e for Scope 1 and about 124,000,000 kg CO2e for Scope 2, with a significant contribution from Scope 3 emissions, which reached approximately 2,529,000,000 kg CO2e. Haleon has set ambitious climate commitments, aiming for a 100% reduction in net Scope 1 and 2 emissions by 2030 compared to a 2020 baseline. This target is supported by a near-term goal to reduce absolute Scope 1 and 2 emissions by 95% by 2030. Additionally, the company aims to reduce Scope 3 emissions by 42% by 2030 from a 2022 baseline. Haleon is committed to achieving net zero carbon emissions across all scopes by 2040, aligning with the Climate Pledge and Race to Zero initiatives. The company has also signed the Science Based Targets initiative (SBTi) commitment, reinforcing its dedication to substantial emissions reductions in line with climate science.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 59,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 37,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Haleon plc's Scope 3 emissions, which decreased by 6% last year and decreased by approximately 7% since 2022, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 59% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Haleon plc has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Haleon plc's sustainability data and climate commitments